
Drug development and manufacturing, with a focus on cancer and infectious diseases.
B
CSR Analysis score
The organization is among the top 20% of most committed organizations, excluding the top 5%, among comparable organizations.
+160,000
Total organizations analyzedAnalysis by axis
Access the detailed report with all sector benchmarks, in-depth competitive analysis and actionable recommendations.
Methodology: Score calculated according to 6 CSR themes (Carbon, Biodiversity, Circular Economy, Sustainable Investments, Governance, Social Impact)
Sources: Public data, CSR reports, documented initiatives, official databases
Last update: May 2026
This analysis is not yet available in English. Please see the French version.
Leading organizations
Takeda
B
Development and commercialization of innovative medicines in various therapeutic areas, including gastrointestinal diseases, rare diseases, plasma-derived therapies, oncology, neuroscience, and vaccines.
GSK
A
Research and development of pharmaceuticals and vaccines focusing on respiratory, immunology, oncology, HIV, and infectious diseases.
Sanofi
B
Development of innovative medicines and vaccines to improve patients' lives, focusing on areas like immunology, oncology, rare diseases, and vaccines.
Initiatives identified among leaders
Réduction des émissions de carbone
“GSK vise à réduire les émissions de carbone et a m...” - GSKUnité de santé mondiale
“L'unité de santé mondiale de Sanofi pasteur fourni...” - SanofiDéveloppement de programmes de responsabilité sociale
“Takeda développe des programmes de responsabilité ...” - Takeda61% of similar organizations communicate on CSR issues
+1873 initiatives collected from 49 similar organizations
Is your score incomplete? Update your CSR information and improve your positioning.
Claim this page
Updated data
Personalized recommendations
Access complete data, competitive analyses and actionable recommendations for your clients.
Comprehensive sector benchmarks
Competitive data
Ready-to-use reports